Cetuximab plus capecitabine as first-line treatment for elderly patients (pts) with advanced colorectal cancer (mCRC). Final analysis of activity and survival according to KRAS status - the TTD-06-01 Spanish Cooperative Group trial
- Rivera, F.
- Gravalos, C.
- Massuti, B.
- Puente, J.
- Marcuello, E.
- Valladares, M.
- Gutierrez, V.
- Layos, L.
- Diaz-Rubio, E.
- Aranda, E.
ISSN: 1359-6349
Año de publicación: 2009
Volumen: 7
Número: 2
Páginas: 216-216
Congreso: 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology
Tipo: Aportación congreso